Investigating the effect of Taryaqe Vabaei in cold-like infections

Phase 3

• Conditions: Condition 1: upper respiratory infections. Condition 2: Upper respiratory infections.; Acute upper respiratory infections; Acute nasopharyngitis [common cold]

• Registration Number: IRCT20231025059862N1
• Lead Sponsor: eyshabour University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

Age 30 to 50 years, ,
presence of mild and outpatient symptoms of upper respiratory infection,

Exclusion Criteria

History of allergy to herbal medicines in the composition,
History of diabetes
History of hypokalemia,cardiovascular disease or digoxin use,
History of hypothyroidism
Pregnancy and breastfeeding
Participation in another clinical study of upper respiratory infection with cold-like symptoms in the 2 months before entering the present study.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of symptoms of upper respiratory infection with cold-like symptoms. Timepoint: On day zero, at the end of the first week and at the end of the second week. Method of measurement: Visual Analogue Scale standard questionnaire and clinical information checklist.